Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
BMC Health Serv Res. 2019 Jun 11;19(1):371. doi: 10.1186/s12913-019-4188-9.
The aim of this study was to assess the accuracy and quality of immunization data on the pentavalent (diphtheria, pertussis, tetanus, hepatitis B and Haemophilus influenzae type B (Hib)) and MMR vaccines as the administrative data of the expanded program on immunization (EPI) in Iran.
We conducted a Data Quality Self-assessment (DQS) survey from October to December 2017. Standardized DQS tools were used to assess the accuracy of reported immunizations data and quality of the immunization monitoring system at the provincial level of the healthcare system including health houses, health posts, rural and urban health centers and district health centers. Multistage cluster random sampling with proportional to size (PPS) weights was used to select target provinces and related health units. Accuracy ratio, quality index (QI), completeness and relevant quality indices of first dose of MMR (MMR1) and third dose of pentavalent vaccines were reported. Corresponding period of the survey was limited to reported administrative immunization data during the first 6 months of 2016.
In relation to accuracy ratio, there was some evidence of under reporting of pentavalent (3rd dose) and MMR1 vaccines in health house units which were 100.94 and 101.1%, respectively. Completeness of reporting for both vaccines at different provincial levels was near 100%. However, the corresponding value for pentavalent (3rd dose) and MMR1 vaccines at the level of urban health centers was 96.67 and 94.17% respectively. Among the five components of a monitoring system data usage and core output had the lowest QI scores in either rural or urban as well as district healthcare centers.
Findings from our DQS survey reveals that administrative reporting of the immunization data was adequate at provincial and district levels of the healthcare centers. Although, addressing the existing concerns regarding timelines of the reporting by health authorities and staffs of EPI is warranted.
本研究旨在评估伊朗扩大免疫规划(EPI)的行政数据中五联疫苗(白喉、百日咳、破伤风、乙型肝炎和流感嗜血杆菌 B 型(Hib))和麻疹、腮腺炎、风疹疫苗的免疫数据的准确性和质量。
我们于 2017 年 10 月至 12 月期间进行了数据质量自我评估(DQS)调查。使用标准化的 DQS 工具评估省级卫生系统(包括卫生所、卫生站、农村和城市保健中心以及地区保健中心)中报告的免疫数据的准确性和免疫监测系统的质量。采用多阶段集群随机抽样,按比例(PPS)权重选择目标省份和相关卫生单位。报告了麻疹、腮腺炎、风疹疫苗(MMR1)和五联疫苗第 3 剂的首剂准确性比值、质量指数(QI)、完整性和相关质量指标。调查的相应时期仅限于 2016 年前 6 个月报告的行政免疫数据。
就准确性比值而言,卫生所单位报告的五联疫苗(第 3 剂)和 MMR1 疫苗存在轻微漏报,分别为 100.94%和 101.1%。不同省级水平的两种疫苗的报告完整性接近 100%。然而,城市保健中心的五联疫苗(第 3 剂)和 MMR1 疫苗的相应数值分别为 96.67%和 94.17%。在监测系统的五个组成部分中,数据使用和核心产出在农村或城市以及地区保健中心的 QI 得分最低。
我们的 DQS 调查结果表明,省级和地区保健中心的免疫数据行政报告是充分的。尽管如此,仍需要解决报告的及时性问题,这是 EPI 卫生当局和工作人员需要关注的问题。